Sarah Mitchell

Sarah completed her BSc Pharmacology at the University of Leeds in 2014, with her dissertation focusing on calcitonin gene-related peptide antagonists for the treatment of migraine. After finishing her degree, Sarah began working in a research laboratory for NHS Blood and Transplant. Following this, Sarah obtained MSc Toxicology awarded from the University of Birmingham in 2016, where her final project involved assessing the toxicity and mechanisms of action of supra-molecular iron, cobalt and nickel cylinders. Sarah then began working at the Safety and Environmental Assurance Centre at Unilever as a Safety Scientist.

Currently, Sarah is in her second year of her PhD at Swansea University supervised by Dr. Martin Clift, working within the In Vitro Toxicology Group lead by Prof. Shareen Doak and Prof. Gareth Jenkins. Her project aims to assess the human health hazards associated with using e-cigarettes using novel advanced 3D cell culture techniques.